parkinson's disease triple agonist glp-1 gip glucagon clinical trial Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative treatment GLP1-GIP receptor co-agonists: a promising

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.

GLP-1 secretion is stimulated by nutrient intake and exerts its effects on glucose homeostasis by stimulating insulin secretion, gastric emptying confiding the food intake, and -cell proliferation

Leah Joseph at Josephcarerx Clarifies the Key Differences Between GLP-1 and Ozempic to Help You Make Informed Health Decisions.

Does GLP-1 cause back pain